FDA NDC Directory · JSON-LD · Markdown

STRENSIQ

NDC 25682-019 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic nameASFOTASE ALFA
Labeler / ManufacturerAlexion Pharmaceuticals, Inc.
Marketing categoryBiologic License Application · App BLA125513
Dosage form / routeSOLUTION · SUBCUTANEOUS
Active ingredientsASFOTASE ALFA (80 mg/.8mL)
Marketing started20151023
Package count1

External sources

Source: openFDA. Public-domain (CC0).